London, 7 Nov 2022: Scientists from Queen Mary University of London and the US pharmaceutical firm CinCor examined whether patients would benefit from taking a drug called Baxdrostat.

 

Those who took a new medicine during a clinical trial were found to have ......
View Details

Related News

• New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)

---

• Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)

---

• Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)

---

• NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)

---

• New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)

---

• Human body's protein recycling system fights bacteria like antibiotics: Study (06-03-2025)

---

• Researchers at IIT Kanpur Identify Crucial Drug Target Receptor for Treating Cancer and Respiratory Diseases (22-02-2025)

---

• Polymer coating designed to prevent blood clot formation on medical implants (21-02-2025)

---

• Repurposing amlodipine, could help manage ADHD symptoms: Study (20-02-2025)

---

• Fluoxetine promotes IL-10–dependent metabolic defenses to protect from sepsis-induced lethality (16-02-2025)

---